New ansamycin antibiotics, naphthoquinomycins A and B, inhibitors of fatty acid synthesis in Escherichia coli.

The Journal of Antibiotics
1986.0

Abstract

Several inhibitors of fatty acid synthesis have recently been noted as a new group of antibiotics which show selective toxicity against procaryotes. Thus, thiolactomycin selectively inhibits the fatty acid synthetase of Escherichia coli (type II) but has little effect on that of mammalian tissues (type I). On the other hand, cerulenin inhibits both type I and type II synthetases. In order to find new inhibitors of the fatty acid synthetase of E. coli (type II), we employed a fatty acid synthetase assay system comprising fraction A and the acyl carrier protein (ACP), which was prepared by essentially the same method as described by MAJERUS et al. from E. coli K12 except that the ACP preparation was used without further purification by DEAE-cellulose and DEAE-Sephadex chromatography. Three active compounds were isolated from the culture filtrate of Streptomyces strain No. S-1998. These antibiotics belonging to the ansamycin group were named naphthoquinomycins A, B and C.

Knowledge Graph

Similar Paper

New ansamycin antibiotics, naphthoquinomycins A and B, inhibitors of fatty acid synthesis in Escherichia coli.
The Journal of Antibiotics 1986.0
New ansamycin antibiotics, naphthoquinomycins A and B, inhibitors of fatty acid synthesis in Escherichia coli.
The Journal of Antibiotics 1986.0
3-Amino-5-hydroxybenzoic Acid in Antibiotic Biosynthesis. XI. Biological Origins and Semisynthesis of Thionaphthomycins, and the Structures of Naphthomycins I and J.
The Journal of Antibiotics 1998.0
Nanaomycins, new antibiotics produced by a strain of Streptomyces. II. Structure and biosynthesis.
The Journal of Antibiotics 1975.0
Discovery of Bacterial Fatty Acid Synthase Inhibitors from a<i>Phoma</i>Species as Antimicrobial Agents Using a New Antisense-Based Strategy
Journal of Natural Products 2006.0
Thiolactomycin-Based Inhibitors of Bacterial β-Ketoacyl-ACP Synthases with in Vivo Activity
Journal of Medicinal Chemistry 2016.0
Nanaomycins, new antibiotics produced by a strain of Streptomyces. I. Taxonomy, isolation, characterization and biological properties.
The Journal of Antibiotics 1975.0
Bioconversion and biosynthesis of nanaomycins using cerulenin, a specific inhibitor of fatty acid and polyketide biosyntheses.
The Journal of Antibiotics 1980.0
Ansamycin Antibiotics as Free Radical Scavengers Isolated from<i>Streptomyces</i>by Using the Bactericidal Action of the Hydroxyl Radical
Bioscience, Biotechnology, and Biochemistry 1996.0
Naphthomycins L–N, Ansamycin Antibiotics from <i>Streptomyces</i> sp. CS
Journal of Natural Products 2012.0